CRP and metabolic syndrome: In a study from Iran, hs-CRP ≥ 3 mg/L was not a significant predictor of CVD among people with dyslipidemia [20] whereas, in another study, hs-CRP > 3 mg/L contributed significantly to an increased odds of CVD in subjects with HDL-C < 60 mg/dL than subjects with HDL-C ≥ 60 mg/dL [33].